Talphera (TLPH)

• Market cap: $51M
• 1 day: -9.89%
• 5 days: 11.61%
• 1 month: 20.5%
• 3 months: 22.59%
• 6 months: -8.21%
• Year to date: -15.33%
• 1 year: 123.23%
• 5 years: -96.31%
• 10 years: -98.19%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 12